Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Personalized Care A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

[Shutterstock: Andrey_Popov] This article is part of our special report Getting the balance right: AI, digitalisation, and respiratory medicine. Chronic obstructive pulmonary disease (COPD ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on ...

Dupixent is the first biologic medicine approved in the U.S. to treat these patients. “People living with inadequately controlled COPD have long awaited new medicines to help manage the daily ...

The Pulmonary and Critical Care Medicine Fellowship is a three-year training program that readies you for a career in any area of pulmonary and critical care medicine that you choose. Our faculty in ...

“With today’s approval, Dupixent once again paves the way and becomes the first and only approved add-on biologic medicine for inadequately controlled COPD, giving patients living with this ...